Enara Bio
PrivateLast Round
Series B
Oct 3, 2024
Total Funding Raised
$84.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Enara Bio operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a Series B round in October 2024.
Enara Bio is a biotechnology company that develops cancer immunotherapies by utilizing its proprietary platforms to discover and validate novel cancer-specific targets known as Dark Antigens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enara Bio Comparables
Compare Enara Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| T-Therapeutics | 84% | |
| Anocca | 82% | |
| T-Knife | 81% |
For institutional investors. Book with your work email.
Enara Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 3, 2024 | ||||
| Series A | Nov 6, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Enara Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B, Series A, Series A Extension |
| SV Health Investors | Series B, Series A Extension, Series A |
| M Ventures | Series B |
| The Francis Crick Institute | Series B |
| Pfizer Ventures | Series B |
| Samsara BioCapital | Series B, Series A, Series A Extension |
| Pfizer Ventures | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 33% MoM.
- Jun 23, 2026
Monthly visitors increased 81% MoM, reaching 3.5K.
For institutional investors. Book with your work email.
Enara Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Enara Bio's valuation, stock price, and market status.
Is Enara Bio a public or private company?
Enara Bio is a private company.
What is the current stock price of Enara Bio?
Enara Bio is a private company, so its shares have no public market price. Caplight tracks Enara Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Enara Bio worth (valuation)?
Valuation information for Enara Bio is not publicly available.
Can I buy Enara Bio stock?
Enara Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Enara Bio's last funding round?
Enara Bio's most recent funding round was Series B on October 3, 2024.
Who are the main investors in Enara Bio?
Key investors in Enara Bio include SV Health Investors, M Ventures, Pfizer Ventures, Pfizer Ventures, M Ventures.
Will Enara Bio IPO soon?
No public IPO plans have been announced for Enara Bio.
How can I track Enara Bio secondary market activity?
Caplight tracks bids, offers, and trades in Enara Bio's shares on secondary markets.